With a CAGR of Around 12%, the UAE Heart Failure Treatment Devices Market to Exceed USD400 Million Mark by 2030

• Overview
• Table of Content
• Research Methodology
• Download Free Sample

The UAE Heart Failure Treatment Devices Market size was valued at around USD 221.85 million in 2024 and is projected to reach USD 442.97 million by 2030. The market is also estimated to grow at a CAGR of around 12% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. Heart failure cases have been reported in huge numbers in recent years in the UAE. The need for treatment devices thereby has been high in the country. Further, the number of obese & overweight individuals has been increasing owing to rapid urbanization that has led people in the country to follow unhealthy & sedentary lifestyles. Obesity being one of the major factors behind cardiovascular diseases has been increasing the number of hospital admissions due to heart failure and arrhythmias in the country, positively driving the Market of Heart Failure Treatment Devices.

Moreover, due to the shortage of organ donors, the number of heart transplants has been less in the country. This has led patients and healthcare providers to rely heavily on devices like; Impella & LVAD to safeguard the patient’s life and bridge the gap until they receive a heart transplant.

Further, the cases of hypertension have been reported in high numbers in the UAE. This hypertension has been the most common risk factor leading to the development of heart failure (HF) among the UAE population. Likewise, ICD & CRT demand has been increasing in the country. Also, in recent times, heart failure medical emergencies have been largely reported in patients with diabetes. More importantly, as patients with diabetes are on the rise in the UAE, the cases of heart failure are expected to increase and contribute to the growing demand for heart failure treatment devices.

Furthermore, in recent years, various technological advancements such as; remote monitoring, tailored therapy, extended battery life, MRI access, etc. in the devices have further contributed to their increased acceptability and demand among healthcare providers in the country, further states the research report, “The UAE Heart Failure Treatment Devices Market Analysis, 2025.”

Segmentation Analysis

The Implantable Cardioverter-Defibrillator (ICD) Segment Holds the Largest Market Share

Based on the product type, the market is further bifurcated into, Implantable Cardioverter-Defibrillator (ICD), Cardiac Resynchronization Therapy (CRT), and Others. Among all, ICD held a significant market share of around 50%. A large number of patients with heart failure & arrhythmias have been increasing the demand for Implantable Cardioverter-Defibrillator. Further, cases of sudden cardiac arrest have been causing huge mortality rates across the UAE causing healthcare providers to largely utilize ICDs to save the lives of patients. Subsequently, the segment’s market has been expanding.

Moreover, congenital heart disease (CHD) cases have been reported in significant numbers in the country. These cause heart failure and mortality in children and if they survive could cause other heart-related complications. ICDs tend to correct life-threatening irregular heartbeats in the patients and reduce mortality rates significantly. As a result, the need for these devices has been there in the UAE.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including Medtronic, Abbott, Boston Scientific Corporation, Biotronik, Johnson & Johnson Services, Inc. (Abiomed), and others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the country?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping across the country?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?